BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260925T080000
DTEND;TZID=America/Halifax:20260925T180000
DTSTAMP:20260803T202514Z
CREATED:20260803T202514Z
LAST-MODIFIED:20260803T202514Z
UID:10000861-1790323200-1790359200@oncodaily.com
SUMMARY:2026 MSK Pulmo-Oncology Symposium
DESCRIPTION:The 2026 MSK Pulmo-Oncology Symposium\, hosted by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on 25 September 2026\, from 8:00 a.m. to 6:00 p.m.\, at the Zuckerman Research Center in New York City\, with in-person and virtual attendance available. \nNow in its fourth year\, the multidisciplinary symposium will examine lung cancer treatment\, pulmonary complications caused by cancer and anticancer therapies\, drug toxicities\, symptom management\, co-existing respiratory conditions\, and emerging AI-based screening and monitoring technologies. Expert presentations\, complex clinical cases\, interactive discussions\, and multidisciplinary panels will support practical decision-making for professionals in pulmonology\, hematology\, oncology\, and related specialties.
URL:https://oncodaily.com/event/pulmo-oncology-symposium-558730
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-12_24_34-AM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:cme@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261010
DTSTAMP:20260822T141250Z
CREATED:20260822T141250Z
LAST-MODIFIED:20260822T141250Z
UID:10000943-1791417600-1791590399@oncodaily.com
SUMMARY:2026 Advances in Prostate Cancer Management: A Multidisciplinary Approach
DESCRIPTION:The 2026 Advances in Prostate Cancer Management: A Multidisciplinary Approach course\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on October 8–9\, 2026\, in New York City\, with both in-person and virtual participation available. \nThe two-day program will focus on the latest advances across the full continuum of prostate cancer care\, bringing together experts in urology\, medical oncology\, radiation oncology\, radiology\, and pathology. \nSessions will address patient evaluation and risk assessment\, active surveillance\, focal therapy\, surgery\, radiation therapy\, systemic treatment\, prevention and management of treatment-related side effects\, genomic testing\, biomarkers\, PSMA PET imaging\, and emerging approaches for localized and advanced prostate cancer. \nThe course is intended for urologists\, urologic oncologists\, medical and radiation oncologists\, pathologists\, radiologists\, and allied health professionals\, and participants will receive access after the course to recorded presentations and faculty slides.
URL:https://oncodaily.com/event/advances-in-prostate-cancer-572294
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-22-2026-06_11_52-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261016T075500
DTEND;TZID=America/Halifax:20261016T150000
DTSTAMP:20260804T175736Z
CREATED:20260804T175653Z
LAST-MODIFIED:20260804T175736Z
UID:10000866-1792137300-1792162800@oncodaily.com
SUMMARY:Benign Hematology and Thrombosis: 2026 Emerging Therapies - MSK
DESCRIPTION:The State of the Art in Benign Hematology\, Hemostasis\, and Thrombosis: 2026 Update in Emerging Therapeutics symposium\, hosted by Memorial Sloan Kettering Cancer Center (MSK)\, will take place in person on 16 October 2026\, from 7:55 a.m. to 3:00 p.m.\, at the Zuckerman Research Center in New York City. \nThe one-day programme will review current and emerging approaches to venous thromboembolism\, pulmonary embolism\, myeloma-associated thrombosis\, factor XI inhibitors\, venous stenting\, post-thrombotic syndrome\, cancer therapy-related cytopenias\, thrombopoietin receptor agonists\, hemophagocytic lymphohistiocytosis\, and immune thrombocytopenia. \nDesigned for hematologists\, oncologists\, advanced practice providers\, trainees\, nurses\, and other healthcare professionals\, the symposium will feature expert presentations\, interactive discussion\, and practical clinical cases. Early registration through 4 September 2026 ranges from $50 to $250\, while general rates range from $100 to $525\, depending on participant category.
URL:https://oncodaily.com/event/benign-hematology-559364
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-09_55_44-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261019T083000
DTEND;TZID=America/Halifax:20261019T173000
DTSTAMP:20260804T190458Z
CREATED:20260804T190458Z
LAST-MODIFIED:20260804T190458Z
UID:10000867-1792398600-1792431000@oncodaily.com
SUMMARY:Rhabdomyosarcoma 2026: Advancing Science\, Improving Outcomes
DESCRIPTION:Rhabdomyosarcoma 2026: Advancing Science\, Improving Outcomes\, jointly presented by the Departments of Pediatrics and Surgery at Memorial Sloan Kettering Cancer Center (MSK)\, will take place on 19 October 2026\, from 8:30 a.m. to 5:30 p.m.\, at the Zuckerman Research Center in New York City\, with in-person\, virtual\, and on-demand participation options. \nThe one-day symposium will focus on multidisciplinary rhabdomyosarcoma care\, including advances in medical treatment\, surgical techniques for primary and metastatic disease\, diagnostic imaging\, translational research\, and the experiences of patients and families. It is designed for physicians\, advanced practice providers\, nurses\, allied health professionals\, and trainees involved in pediatric oncology. Registration costs $299 for physicians\, $249 for advanced practice providers\, $199 for nurses and other healthcare professionals\, $100 for residents and fellows\, and $525 for industry professionals; MSK employees may attend free of charge.
URL:https://oncodaily.com/event/rhabdomyosarcoma-559379
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-10_07_25-PM-1.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20261025
DTSTAMP:20260822T143706Z
CREATED:20260822T143706Z
LAST-MODIFIED:20260822T143706Z
UID:10000944-1792713600-1792886399@oncodaily.com
SUMMARY:2026 Accelerated Review in Medical Oncology
DESCRIPTION:The 2026 Accelerated Review in Medical Oncology\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on October 23–24\, 2026\, in New York City.  \nThis intensive two-day\, in-person course is designed as a high-yield review for hematology/oncology fellows preparing for initial board certification and medical oncologists preparing for certification or recertification in Medical Oncology. \nThe program will review the diagnosis\, staging\, and management of solid tumors and malignant hematologic disorders\, with particular emphasis on common\, curable malignancies and other high-impact topics frequently tested on the American Board of Internal Medicine (ABIM) examinations. \nContent will be delivered through concise micro-lectures\, and participants will receive a course workbook with summary notes for each topic. The course will conclude with a networking reception on Saturday evening. Virtual participation is not available.
URL:https://oncodaily.com/event/accelerated-review-in-medical-oncology-572301
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-22-2026-06_36_16-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261030T080000
DTEND;TZID=America/Halifax:20261030T170000
DTSTAMP:20260902T175503Z
CREATED:20260902T175440Z
LAST-MODIFIED:20260902T175503Z
UID:10000990-1793347200-1793379600@oncodaily.com
SUMMARY:2026 Advances in Chronic Graft-Versus-Host Disease
DESCRIPTION:The 2026 Advances in Chronic Graft-Versus-Host Disease: Translating Evidence into Practice conference\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on October 30\, 2026\, from 8:00 AM to 5:00 PM ET\, at the Zuckerman Research Center in New York City. \nThis one-day\, in-person multidisciplinary programme will focus on improving the understanding and management of adult and pediatric chronic graft-versus-host disease (cGVHD). \nExperts from hematology\, transplantation\, dermatology\, ophthalmology\, gynecology\, pulmonology\, pharmacy\, dentistry\, nutrition\, and supportive care will address the biology of cGVHD\, organ-specific manifestations\, systemic therapy selection and sequencing\, patient-reported outcomes\, oral cancer screening\, pharmacy considerations\, AI-driven clinical data mining\, digital tools for GVHD care\, and development of multidisciplinary GVHD clinics. \nThe programme also includes interactive case discussions\, adult and pediatric management sessions\, a debate on combination therapy\, and a networking reception. Stephanie Lee\, MD\, MPH\, of Fred Hutchinson Cancer Center\, will deliver the keynote address. The activity offers up to 7.25 AMA PRA Category 1 Credits™\, as well as eligible ABIM\, ABP\, and ABS MOC/CC credits. \n 
URL:https://oncodaily.com/event/graft-versus-host-disease-579681
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/GVHD2026_16x9.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
END:VCALENDAR